• 1. Aggregation of the metallocycles {Cu8} and {Cu20} using [Cu(bp)] units (H2bp = bis(2-hydroxybenzyl)amine): structures and magnetic properties?
  Mei-Yu Xu,Ya-Ting Wang,Qing-Ling Ni,Zi-Hao Zhang,Guang-Ming Liang,Liu-Cheng Gui Dalton Trans., 2016,45, 4993-4997
• 2. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 3. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 4. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 5. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550

Professional Introduction to 3-nitro-2-Pyridineethanol (CAS No. 918153-28-3)

3-nitro-2-Pyridineethanol, identified by the chemical compound code CAS No. 918153-28-3, is a significant molecule in the field of chemical and pharmaceutical research. This compound, featuring a nitro group and a pyridineethanol moiety, has garnered attention due to its versatile applications in synthetic chemistry and potential biological activities. The structural uniqueness of 3-nitro-2-Pyridineethanol positions it as a valuable intermediate in the development of various pharmacological agents.

The molecular structure of 3-nitro-2-Pyridineethanol consists of a pyridine ring substituted with a nitro group at the 3-position and an ethanol side chain at the 2-position. This configuration imparts distinct chemical properties that make it useful in multiple synthetic pathways. The presence of the nitro group enhances reactivity, allowing for further functionalization, while the ethanol moiety provides a handle for further derivatization, making it a versatile building block in medicinal chemistry.

In recent years, 3-nitro-2-Pyridineethanol has been explored in the context of drug discovery and development. Its structural features suggest potential applications in the synthesis of bioactive molecules targeting various therapeutic areas. For instance, researchers have investigated its role in developing novel antimicrobial agents, where the nitro group can serve as a pharmacophore for interacting with bacterial enzymes. Additionally, its derivatives have shown promise in anti-inflammatory and anticancer research, highlighting its significance in medicinal chemistry.

The synthesis of 3-nitro-2-Pyridineethanol involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic techniques, such as catalytic hydrogenation and nucleophilic substitution, are often employed to construct the desired molecular framework. The growing interest in this compound has led to optimizations in synthetic protocols, making it more accessible for industrial-scale production.

One of the most compelling aspects of 3-nitro-2-Pyridineethanol is its potential in developing small-molecule drugs with improved pharmacokinetic properties. The pyridine ring is a common motif in many bioactive compounds due to its ability to interact with biological targets through hydrogen bonding and hydrophobic effects. By incorporating this moiety into drug candidates, researchers aim to enhance binding affinity and reduce off-target effects.

The nitro group in 3-nitro-2-Pyridineethanol also plays a crucial role in modulating drug activity. Nitroaromatic compounds have been extensively studied for their therapeutic potential, with modifications of the nitro group leading to significant changes in pharmacological properties. For example, reduction of the nitro group can yield aminoaromatic compounds that exhibit different biological activities. This flexibility makes 3-nitro-2-Pyridineethanol a valuable scaffold for designing novel therapeutics.

In conclusion, 3-nitro-2-Pyridineethanol (CAS No. 918153-28-3) is a multifaceted compound with significant implications in pharmaceutical research. Its unique structural features enable diverse applications in drug development, from antimicrobial agents to anticancer therapeutics. The ongoing exploration of its synthetic pathways and biological activities underscores its importance as a key intermediate in modern medicinal chemistry. As research continues to uncover new possibilities, 3-nitro-2-Pyridineethanol is poised to remain at the forefront of chemical and pharmaceutical innovation.

• 1346534-62-0(2-Ethyl-3-nitro-pyridine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)